Currently active funding opportunity announcements (FOAs) for neuroscience research include the following Requests for Applications (RFAs), Program Announcements (PAs), and PAs with special reviews (PARs), as well as Notices (NOTs).
FOAs on which NICHD is the primary sponsor
- NOT-HD-22-036 Notice of Intent to Publish a FOA for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- NOT-HD-21-032 Notice of Special Interest (NOSI): Reduction of Sudden Unexpected Infant Death and Sudden Infant Death Syndrome
- NOT-HD-21-026 NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
- NOT-HD-21-025 NOSI: Reproductive Health, Pregnancy, and Parenting Among Women with Disabilities
- NOT-HD-20-032 NOSI: Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health
- NOT-HD-20-031 NOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
- NOT-HD-20-026 NOSI: Optimizing Precision Treatment of Gynecologic, Reproductive and Obstetrical Outcomes in Adolescents and Adults with PCOS and Associated Comorbid Conditions (Clinical Trial Optional)
- NOT-HD-20-022 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens
- NOT-HD-20-021 NOSI: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
- NOT-HD-20-009 Notice of Interest in Advancing Research on FMR1-Associated Conditions
- NOT-HD-20-004 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- NOT-HD-19-038 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- NOT-HD-19-037 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R01)
- NOT-HD-19-022 NOSI: Research on Emergency Medical Services for Children (EMSC)
- NOT-HD-19-020 NOSI: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain
- PAR-21-355 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
- PAR-21-354 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 Clinical Trial Optional)
- PAR-21-353 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 Clinical Trial Optional)
- PAR-21-229 Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
- PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
- PAR-20-298 Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
- PAR-20-282 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
- PAR-20-281 Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
- PAR-20-137 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
- PAR-20-064 Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
FOAs on which NICHD is a partner
- NOT-EB-21-008 Notice of NIH Participation in the National Robotics Initiative
- NOT-EB-21-001 NOSI: Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
- NOT-HD-22-027 Notice of NICHD Participation in NOT-MH-20-110, “Collaborative Research in Computational Neuroscience (CRCNS) National Science Foundation Innovative Approaches to Science and Engineering Research on Brain Function" (apply via NSF 20-609)
- NOT-HD-22-009 NOSI: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
- NOT-MD-19-001 NOSI: Research on the Health of Sexual and Gender Minority (SGM) Populations
- NOT-NS-22-003 NOSI: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
- NOT-NS-20-005 NOSI: Research in the Emergency Setting
- NOT-OD-21-087 NOSI: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
- PA-21-201 Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
- PA-21-200 Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
- PA-21-199 Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
- PA-20-227 Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)
- PAR-22-101 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
- PAR-22-100 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- PAR-21-343 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
- PAR-21-342 Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
- PAR-21-319 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- PAR-21-311 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)
- PAR-21-281 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trial Not Allowed)
- PAR-21-280 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)
- PAR-21-100 Music & Health: Understanding and Developing Music Medicine (R01 Clinical Trial Optional)
- PAR-21-099 Music & Health: Understanding and Developing Music Medicine (R21 Clinical Trial Optional)
- PAR-20-180 Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)
- PAR-20-179 Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
- PAR-20-169 National Centers for Biomedical Engineering and Bioimaging (NCBIB) (P41 Clinical Trials Optional)
- PAR-19-292 Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed)
- PAR-19-276 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- PAR-19-274 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- PAR-19-163 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
- PAR-19-158 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- PAR-18-939 Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
- PAR-18-937 Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
- RFA-NS-21-026 BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-NS-21-027 BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
In addition, neuroscience researchers may also be interested in FOAs for the following NIH-wide initiatives in which NICHD participates:
- Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative
- Helping to End Addiction Long-termSM (HEAL) Initiative
- INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
- NIH Blueprint for Neuroscience Research
- NIH Strategic Response to COVID-19 Research
BACK TO TOP